Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the pneumococcal conjugate vaccine, or PCV. The report with the updated ...

Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines (PCVs) for treating ...

Abbott announced the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over six weeks of age. Abbott’s PCV-14 valent (Pneumococcal Conjugate Vaccine), offers broad ...

For the first time, the Centers for Disease Control and Prevention has lowered the recommended age for those who should get a pneumococcal ... may have a milder form of the infection known as ...

The Centers for Disease Control and Prevention (CDC) on Wednesday adopted a recommendation from its scientific advisory panel to lower the age for pneumococcal vaccination from 65 to 50 years old.

Dear Savvy Senior: I recently turned 65 and would like to know if I am supposed to get the pneumonia vaccine? And if so, which type of vaccine do I need, and is it covered by Medicare?

KPBS reporter Katie Hyson says this year’s consent form is resurfacing years of debate around the program and its effects on Black and Latino students. The San Diego Unified School District has ...

Merck & Co (MSD) has won US Food and Drug Administration (FDA) approval for its 21-valent pneumococcal vaccine, Capvaxive, for the prevention of invasive pneumococcal disease and pneumococcal ...